Literature DB >> 19901285

Comparison of four methods to quantify Equid herpesvirus 1 load by real-time polymerase chain reaction in nasal secretions of experimentally and naturally infected horses.

Nicola Pusterla1, Stephen B Hussey, Samantha Mapes, Christian M Leutenegger, John E Madigan, Gregory L Ferraro, W David Wilson, D Paul Lunn.   

Abstract

The objective of the current study was to compare the performance of 4 methods to quantify Equid herpesvirus 1 (EHV-1) by real-time polymerase chain reaction (PCR) in nasal secretions from experimentally and naturally infected horses. Nasal secretions were collected on the challenge day and daily thereafter for 13 days from 4 experimentally infected horses. Additional nasal swabs were collected from 30 horses with clinical signs consistent with natural EHV-1 infection. Absolute quantitation of EHV-1 target molecules was performed using standard curves for EHV-1 and equine glyceraldehyde-3-phosphate dehydrogenase, and DNA yield, and was expressed as EHV-1 glycoprotein B (gB) gene copies per million nucleated nasal cells, EHV-1 gB gene copies per entire swab, EHV-1 gB gene copies per 1 microl of purified DNA, and EHV-1 gB gene copies per 1 ng of template DNA. The study results showed that all 4 calculation methods yielded comparable results between experimentally and naturally infected horses, and that the different methods were significantly correlated with each other. Reporting of quantitative results for EHV-1 viral load in nasal swabs collected from infected horses constitutes an important advance in both the research and diagnostic fields, allowing one to determine the infectious risk of affected horses, disease stage, or response to antiviral therapy. However, protocols that normalize the PCR results against a preselected volume of DNA or nasal secretions are likely to be more prone to variations than protocols that calculate the load for the entire swab, incorporate a housekeeping gene, or use a constant amount of extracted DNA.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19901285     DOI: 10.1177/104063870902100611

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  5 in total

1.  Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): infection with Equine Herpesvirus-1.

Authors:  Søren Saxmose Nielsen; Julio Alvarez; Dominique Joseph Bicout; Paolo Calistri; Elisabetta Canali; Julian Ashley Drewe; Bruno Garin-Bastuji; José Luis Gonzales Rojas; Christian Gortázar; Mette Herskin; Virginie Michel; Miguel Ángel Miranda Chueca; Helen Clare Roberts; Barbara Padalino; Paolo Pasquali; Hans Spoolder; Karl Ståhl; Antonio Velarde Calvo; Arvo Viltrop; Christoph Winckler; Andrea Carvelli; Romain Paillot; Alessandro Broglia; Lisa Kohnle; Francesca Baldinelli; Yves Van der Stede
Journal:  EFSA J       Date:  2022-01-12

2.  Investigation of the Use of Non-Invasive Samples for the Molecular Detection of EHV-1 in Horses with and without Clinical Infection.

Authors:  Danielle Price; Samantha Barnum; Jenny Mize; Nicola Pusterla
Journal:  Pathogens       Date:  2022-05-13

3.  Multiple molecular detection of respiratory viruses and associated signs of airway inflammation in racehorses.

Authors:  Nadia Doubli-Bounoua; Eric A Richard; Albertine Léon; Pierre-Hugues Pitel; Stéphane Pronost; Guillaume Fortier
Journal:  Virol J       Date:  2016-11-29       Impact factor: 4.099

4.  Molecular Monitoring of EHV-1 in Silently Infected Performance Horses through Nasal and Environmental Sample Testing.

Authors:  Nicola Pusterla; Samantha Barnum; Amy Young; Eric Mendonsa; Steve Lee; Steve Hankin; Skyler Brittner; Carrie J Finno
Journal:  Pathogens       Date:  2022-06-24

5.  Outbreak of equid herpesvirus 1 abortions at the Arabian stud in Poland.

Authors:  Karol Stasiak; Magdalena Dunowska; Jerzy Rola
Journal:  BMC Vet Res       Date:  2020-10-06       Impact factor: 2.741

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.